AMLYCAS (Class 5)

The trademark application number 3871727 is currently marked as "Protection Granted" in the official trademark registry.

The trademark application number 3871727 is owned by Prothena Therapeutics Limited.

Trademark application number 3871727 is filed under Class 5, which relates to the specified goods and services.

Yes, trademark application number 3871727 was published in Journal No. 1857.

Trademark application number 3871727 relates to "Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes.".